Overview

Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this observational study is to collect efficacy and safety data in diabetic patients with acute hyperglycemia using NovoRapid™ FlexPen™ as per normal clinical practice.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin Aspart